TV

Skip to main navigation Skip to main content
Psychology
Phone:
(023) 8059 5577
Email:
Samuele.Cortese@soton.ac.uk

ʰǴڱǰܱǰٱ M.D., PhD.

Professor of Child and Adolescent Psychiatry

Professor Samuele Cortese's photo

Samuele Cortese is Professor of Child and Adolescent Psychiatry within Psychology and Medicine at the TV.

1999: M.D. (summa cum laude), Verona University, Verona, Italy

2004: Specialty in Child Neuropsychiatry (summa cum laude), Verona University, Verona, Italy (equivalent CCT in child and adolescent psychiatry obtained by the GMC on 27.07.12)

2005-2006: Clinical Research Assistant, Child and Adolescent Psychopathology Unit, Robert Debré Hospital, Paris VII University, Paris, France

2006-2008: Chef de Clinique, Child and Adolescent Psychopathology Unit, Robert Debré Hospital, Paris VII University, Paris, France

2009: PhD. in Multimodal Imaging in Biomedicine, Verona University, Verona, Italy. Given the fulfilment of the prerequisites proposed by the European University Association (1992), I was awarded with the additional label of “DOCTOR EUROPAEUS”.

2009: Research Associate, Child Neuropsychiatry Unit, Mother-Child and Biology-Genetics Department, Verona University, Verona, Italy

2010: Assistant Professor, Tours University, France

2010-2013: Marie Curie Post-Doctoral Fellow (International Outgoing Fellowship for Carer Development), Institute for Pediatric Neuroscience, New York University Child TV Center, NYC, NY, USA & Department of Life and Reproduction Sciences, Verona University, Verona, Italy

2014 onwards: Honorary Clinical Associate Professor of Child Psychiatry, University of Nottingham, UK

2014 to date: Adjunct Associate Professor of Child Psychiatry, New York University, NY, USA

2015 onwards: Honorary Consultant in Child and Adolescent Psychiatry, Solent NHS Trust

2015-2019: Clinical Associate Professor, TV

2019 onwards: Professor of Child and Adolescent Psychiatry, TV

Research interests

My research aims to inform clinical decision making in child and adolescent psychiatry, with a specific focus on ADHD (and its related neurodevelopmental conditions), and sleep disorders. My studies are mainly based on advanced meta-analytic approaches, as well as large epidemiological datasets.

In 2020, I was included in the list of the world's most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations in the field of psychiatry/psychology in 2019 in . In 2021 I also ranked #1 worldwide in terms of expertise on Attention-Deficit/Hyperactivity Disorder (ADHD) and #2 in child mental health according to .

Network of research collaborations

Network of research collaborations
Network of research collaborations

COH

Since 2020, I am the coordinator for the UK of the world’s largest survey on the mental and physical corelates of the Covid-19 pandemic, Collaborative Outcomes study on Health and Functioning during Infection Times ( ).

The study is based on an ANONYMOUS survey open to everyone aged 6 or more. It is available in 30 languages and it takes about 30 minutes for adults and 20 for children/adolescents.

Please help us understand the physical and mental impact of the Covid-19 pandemic by completing the survey .

Research projects

Comparative efficacy and  pharmacological and non-pharmacological treatments

Association between mental disorders and somatic conditions (AMASU project)

Sleep disorders in children with neurodevelopmental disorders

Prevalence of neurodevelopmental disorders

OPTIMA: On-Line Parent Training for the Initial Management of ADHD referral

Effects of external Trigeminal Nerve Stimulation in ADHD and mechanisms of action

Stimulant Medication for ADHD and Tics - Understanding Response versus Non-stimulants (SATURN study): a randomised trial of the clinical and cost-effectiveness of methylphenidate versus guanfacine for ADHD in children and young people with a co-existing tic disorder

Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT)

ACTIVE GRANTS

NIHR (PgfAR) Digital Sleep Support for Children with AttentionDeficit/Hyperactivity Disorder (The DISCA study)- 2022-2028. £2.280.000,00. Joint Lead

NIHR (RfPB))Comparing pharmacological and non-pharmacological interventions for adults with Attention-Deficit/Hyperactivity Disorder (ADHD): systematic review and network meta-analysis -2022-2025. £149.400,00. Lead

NIHR (EME) Effects of external Trigeminal Nerve Stimulation in ADHD and mechanisms of action (ATTENS). 2021-2025. £1,911,504.82. Co-I

NIHR ARC Wessex. 2021-2015. £ 749,843 (total). Co-lead in Healthy Community team

NIHR (HTA) Stimulant Medication for ADHD and Tics – Understanding Response versus Non-stimulants (SATURN study): a randomised trial of the clinical and costeffectiveness of methylphenidate versus guanfacine for ADHD in children and young people with a co-existing tic disorder (Saturn). 2021-2025. £ 1,628,868.50. Co-I.

NIHR (PgfAR) On-Line Parent Training for the Initial Management of ADHD referral (OPTIMA)- RP-PG-0618- 20003. 2021-2025. £1,957,977.00. Co-I

Solent NHS Trust, Research Capability Funding (NIHR Funding). 2021-2022. £ 17,300. Lead

Research group

Centre for Innovation in Mental Health (CiMH)

Research project(s)

On-Line Parent Training for the Initial Management of ADHD referral (OPTIMA)

Medication for ADHD in children and young people with a co-existing tic disorder (SATURN)

Comparative Efficacy and Tolerability of ADHD Medications

Sleep Disturbances in Individuals with Neurodevelopmental Disorders

The project included a series of meta-analyses in children. adolescents, adults with ADHD, ASD and other neurodevelopmental disorders to quantify the association between neurodevelopmental disorders and subjective as well as objective alterations of sleep.

Local roles:

  • Member of the Ethic Committee Reviewers group (2016-2020)
  • Member of the Committee of the Southern branch of the Association for Child and Adolescent Mental Health (ACAMH)

National roles:

  • Branch Liaison Officer of the Association for Child and Adolescent Mental Health (ACAMH) (2016-2020)
  • Academic Secretary of the Association for Child and Adolescent Mental Health (ACAMH)
  • Member of the Board of the Association for Child and Adolescent Mental Health (ACAMH)
  • Member of the Child Psychiatry Research Society
  • Member of the British Association of Psychopharmacology (BAP) child and adolescent module faculty

International roles:

  • Member of the European ADHD Guidelines Group (EAGG)
  • Member elected of the Steering Committee of the European Network for Hyperkinetic Disorders (Eunethydis)
  • Member of the Child and Adolescent network of the European College of Neurosychopharmacology (ECNP)
  • Member of the Guidelines group of the Canadian ADHD Resource Alliance (CADDRA)

Editorial roles:

  • Deputy Editor for the Journal of the American Academy of Child and Adolescent Psychiatry
  • Deputy Editor of Evidence Based Mental Health (BMJ Group)
  • Associate Editor of Child and Adolescent Mental Health (CAMH)
  • Member of the Advisory Board of the Journal of Child Psychology and Psychiatry and allied disciplines
  • Member of the Editorial Board of CNS Drugs
  • Member of the Editorial Board of the Journal of Child and Adolescent Psychopharmacology
Professor Samuele Cortese
Samuele.Cortese@soton.ac.uk
Contact number: 023 8059 5577 (extension 25577)

Room Number : 44/4059

Privacy Settings